Halozyme Therapeutics
HALO
#2253
Rank
C$11.82 B
Marketcap
C$99.66
Share price
1.06%
Change (1 day)
34.08%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): C$0.65 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are C$1.39 Billion. a decrease over its 2024 earnings that were of C$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 C$0.65 B-16.2%
2024 C$0.77 B59.94%
2023 C$0.48 B39.94%
2022 C$0.34 B0.16%
2021 C$0.34 B92.2%
2020 C$0.18 B-278.96%
2019 -C$0.11 Billion-9.45%
2018 -C$0.12 Billion-229.51%
2017 C$85.89 M-160.48%
2016 -C$0.15 Billion216.03%
2015 -C$44.94 Million-52.86%
2014 -C$95.33 Million-18.09%
2013 -C$0.12 Billion55.88%
2012 -C$74.67 Million169.94%
2011 -C$27.66 Million-63.44%
2010 -C$75.65 Million-7.19%
2009 -C$81.51 Million15.91%
2008 -C$70.32 Million83.89%
2007 -C$38.24 Million78.1%
2006 -C$21.48 Million16%
2005 -C$18.51 Million45.24%
2004 -C$12.75 Million682.42%
2003 -C$1.63 Million1659.12%
2002 -C$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.21 B 5,464.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.76 B 2,168.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.39 B 6,566.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.67 B 1,540.37%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-C$0.71 Billion-208.81%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C$1.96 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA